CClinicalTrials.gg
CompletedNCT07092735Updated Jul 30, 2025

Neuro-Athletic Training in Football

An interventional study of Neuro-Athletic Training and Standard Training in Athletic Performance, Neurocognitive Function and Proprioception, sponsored by Ankara Yildirim Beyazıt University. Completed at 1 site in Turkey (Türkiye). Open to male participants aged 18 Years to 23 Years, including healthy volunteers. Per ClinicalTrials.gov, last updated 2025-07-30.

Sponsored by Ankara Yildirim Beyazıt University · Not applicable, Interventional, and Treatment

From the registry’s dates

  • Registered 1 year after the study started (first participant enrolled Jun 2024, registered Jul 2025).
Phase
Not applicable
Study type
Interventional
Enrollment
56
Allocation
Randomized
Ages
18 Years to 23 Years
Sex
Male
01

Study summary

This randomized controlled trial evaluates the effectiveness of an 8-week neuro-athletic training (NAT) program in enhancing sport-specific skills and physical capacities in elite male football players aged 18-23 years. Participants were randomly assigned to a NAT intervention group or a control group that maintained standard training. The NAT program involved oculomotor, vestibular, and proprioceptive drills. Primary outcomes include passing and shooting accuracy; secondary outcomes include flexibility and isokinetic knee strength.

02

Conditions studied

  • Athletic Performance
  • Neurocognitive Function
  • Proprioception
  • Soccer
  • Sensorimotor Integration
  • Eye Movements
  • Neuroathletic Training
03

In context

Lead sponsor

Ankara Yildirim Beyazıt University is the lead sponsor of 228 studies on the registry; 53 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years to 23 Years
Sexes eligible
Male
Accepts healthy volunteers
Yes

Inclusion criteria

  • Male football players aged 18-23 years
  • Active in the Turkish Regional Amateur League (2023-2024 season)
  • Minimum of 5 years of uninterrupted football training experience
  • No known neuromuscular or visual impairments
  • Participation in at least four football training sessions per week
  • Willingness and ability to participate in all assessments and training sessions
  • Provision of written informed consent

Exclusion criteria

Exclusion Criteria:

  • History of orthopedic or neurological surgery within the past year
  • Acute or chronic musculoskeletal injuries preventing full participation
  • Uncorrected visual impairment
  • Use of medications affecting neuromuscular performance or coordination
  • Previous or concurrent involvement in structured neuromuscular or neuro-athletic training programs
  • Irregular attendance to training sessions (>20% missed)
  • Any condition precluding safe participation, as determined by medical staff
05

Study design

Phase
Not applicable
Primary purpose
Treatment
Allocation
Randomized
Intervention model
Parallel assignment
Masking
Single (Outcomes assessor)
Enrollment
56 participants (actual)

Study arms

  • Experimental
    Neuro-Athletic Training (NAT) Group

    Participants receive a structured 8-week NAT program including oculomotor, vestibular, and proprioceptive drills, 3 sessions/week (35-45 minutes each).

    Behavioral: Neuro-Athletic Training

  • Active comparator
    Standard Training Group

    Participants continue their standard in-season football training program without any NAT components.

    Other: Standard Training

Interventions

  • BehavioralNeuro-Athletic Training

    Participants receive a structured 8-week NAT program including oculomotor, vestibular, and proprioceptive drills, 3 sessions/week (35-45 minutes each).

  • OtherStandard Training

    Participants continue their standard in-season football training program without any NAT components.

06

What researchers measure

Primary outcomes

  1. Passing Accuracy (Mor-Christian Passing Test)

    Measured as a score (max 120) based on 12 passes from 7, 8.5, and 10 meters toward a mini-goal. Assessed pre- and post-intervention.

    Time frame: Pre-intervention (baseline) and post-intervention (after 8 weeks).

  2. Shooting Accuracy (Mor-Christian Shooting Test)

    Measured as a score (max 80) based on 16 shots from 14.5 meters toward four 45 cm targets. Assessed pre- and post-intervention.

    Time frame: Pre-intervention (baseline) and post-intervention (after 8 weeks).

Secondary outcomes

  1. Flexibility (Sit-and-Reach Test)

    Measured in centimeters using a standard sit-and-reach box, assessing hamstring and lower back flexibility.

    Time frame: Pre-intervention (baseline) and post-intervention (after 8 weeks)

  2. Isokinetic Knee Strength (ISOMED 2000 Dynamometer)

    Concentric peak torque of quadriceps and hamstrings at 60°/s (5 repetitions) and 180°/s (15 repetitions), normalized to body mass (Nm/kg), and hamstring-to-quadriceps (H:Q) ratio.

    Time frame: Pre-intervention (baseline) and post-intervention (after 8 weeks).

07

Study locations

1 site
  • Balikesir University
    Balıkesir, Turkey (Türkiye)
08

References and documents

Individual participant data

Plan to share: No — Individual participant data (IPD) will not be shared due to privacy concerns and institutional data protection policies.

No publications or documents are linked to this record.

09

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Jul 30, 2025, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT07092735
Lead sponsor
Ankara Yildirim Beyazıt University
Responsible party
Sponsor
First posted
Jul 30, 2025
Start date
Jun 12, 2024
Primary completion
Jul 12, 2024
Completion
Aug 12, 2024
Last update
Jul 30, 2025

Oversight

Data monitoring committee
Yes
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Jul 2025. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion